News
"The DEA is creating a regulatory paradox where science is stifled and illegal activity is tolerated. Thomas Prevoznik, one unelected bureaucrat should not have the power to derail federally ...
Providers and Vendors Encouraged to Address Patient Concerns at e-Health Canada 2025 Conference in Toronto, June 1-3 TORONTO, ...
Surgical Retractors Market: A 6-7% CAGR Growth Forecast Fueled by Advancements in Technology by 2028
The Surgical Retractors Market is expected to witness a CAGR of 6-7% during the forecast period. The market is propelled by ...
Through the help of Dr. Katinka van der Merwe at The Spero Clinic, Emma was able to get her life back from CRPS. FAYETTEVILLE ...
The Ligation Devices Market is expected to witness a CAGR of 6-7% by 2028. The key factors driving the market are the rising ...
IntroductionThe global in vitro fertilization market has entered a phase of consistent and transformational growth driven by ...
Market is undergoing a transformative phase, driven by the increasing demand for precision medicine and targeted therapies.
EBITDA before special items decreases to 4.085 billion euros (minus 7.4 percent) / Moderate decline in sales (Fx & p adj.) at ...
SHELTON, CT / ACCESS Newswire / May 16, 2025 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company"), reports that it has filed its Quarterly Report on Form 10-Q for the quarter ending March 31, 2025 ...
Leading life science executives, government officials, academic leaders, and investors gather for two day off-the-record ...
WHEAT RIDGE, CO / ACCESS Newswire / May 15, 2025 / Lifeloc Technologies, Inc. (OTC:LCTC), a global leader in the development ...
AQILION AB (publ) today announces that the US Food and Drug Administration (FDA) has approved Aqilion's IND (investigational new drug) application for the drug candidate AQ280. The first study in the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback